Claire Palles Selected Research

N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)

1/2022	The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management.
1/2020	Reply to: "Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claire Palles Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 10/2012
15	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2011
5	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 07/2013
5	Adenocarcinoma 01/2021 - 10/2012
3	COVID-19 01/2022 - 01/2020
3	Barrett Esophagus (Barrett's Esophagus) 01/2021 - 10/2012
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016 - 09/2014
3	Breast Neoplasms (Breast Cancer) 05/2012 - 01/2009
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Dihydropyrimidine Dehydrogenase Deficiency 03/2021 - 12/2015
2	Obesity 01/2021 - 01/2020
2	Genomic Instability 01/2018 - 07/2013
1	Hand-Foot Syndrome 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Vomiting 11/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2021
1	Neutropenia 11/2021
1	Abdominal Obesity 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Microsatellite Instability 01/2019
1	Gastroesophageal Reflux (GERD) 01/2019
1	Carcinogenesis 01/2018
1	Genetic Risk Score 01/2017
1	Pediatric Obesity 07/2016
1	Carcinoma (Carcinomatosis) 04/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Dyskinesias (Dyskinesia) 01/2016
1	Hiatal Hernia 10/2012

Drug/Important Bio-Agent (IBA)

5	Exonucleases (3' 5' Exonuclease)IBA 10/2021 - 07/2013
4	Capecitabine (Xeloda)FDA Link 01/2022 - 04/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
4	Biological ProductsIBA 01/2016 - 09/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 07/2013
3	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021 - 07/2013
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
2	N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)IBA 01/2022 - 01/2020
2	XELOXIBA 01/2022 - 11/2021
2	hydroxide ionIBA 11/2021 - 10/2019
2	25-hydroxyvitamin DIBA 11/2021 - 01/2020
2	Vitamin D FDA LinkGeneric 11/2021 - 10/2019
2	CholesterolIBA 01/2021 - 01/2017
2	Insulin-Like PeptidesIBA 01/2021 - 01/2009
2	Hormones (Hormone)IBA 05/2012 - 01/2009
2	SteroidsIBA 05/2012 - 01/2009
1	Cetuximab (Erbitux)FDA Link 11/2021
1	LDL CholesterolIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	LipidsIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Biological FactorsIBA 01/2020
1	CalciumIBA 01/2020
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2020
1	SeleniumIBA 01/2020
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020
1	Thymidylate SynthaseIBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	3' Untranslated Regions (3' UTR)IBA 01/2020
1	MutL Protein Homolog 1IBA 01/2019
1	Pattern Recognition ReceptorsIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2017
1	Dietary Fats (Dietary Fat)IBA 10/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 10/2016
1	ORALIT (ORS)IBA 07/2016
1	Tumor Biomarkers (Tumor Markers)IBA 02/2016
1	mouse RECS1 proteinIBA 01/2016
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 12/2015
1	DNA replicaseIBA 07/2015
1	Granzymes (Granzyme)IBA 07/2015
1	ProdrugsIBA 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	AcidsIBA 10/2012
1	Cytochrome P-450 CYP3AIBA 05/2012
1	Estrone FDA Link 05/2012
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 06/2011
1	Estrogen Receptor alphaIBA 03/2011
1	ProlactinIBA 01/2009

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 04/2016
5	Therapeutics 01/2022 - 01/2017
1	Immunotherapy 01/2022
1	Adjuvant Chemotherapy 04/2016
1	Aftercare (After-Treatment) 04/2016